4D pharma: 4D PHARMA : "4D pharma") RECEIVES NOTICE OF DELISTING FROM NASDAQ - Form 6-K

(marketscreener.com) 4D PHARMA PLC RECEIVES NOTICE OF DELISTING FROM NASDAQ Leeds, UK, 28 June, 2022 - 4D pharma plc , a pharmaceutical company leading the development of Live Biotherapeutic products , a novel class of drug derived from the microbiome, today announces that on June 27, 2022, it received written notice from The Nasdaq Stock...https://www.marketscreener.com/quote/stock/4D-PHARMA-PLC-56171591/news/4D-PHARMA-ldquo-4D-pharma-rdquo-RECEIVES-NOTICE-OF-DELISTING-FROM-NASDAQ-Form-6-K-40857968/?utm_medium=RSS&utm_content=20220629